In this study, we first assessed the expression levels of SOX4 in 3 pairs of clinical fresh tissues, 55 cases of clinical paraffin-embedded NPC tissues, and NPC cell line CNE2. This evidence concerns the gene SOX4 and nasopharyngeal carcinoma.